The Spineway Group announced the appointment of Sandrine Carle as Deputy Chief Executive Officer. Ms. Carle joined Spineway in July 2022, at the time of the acquisition of Spine Innovations, where she was CEO. She was instrumental in the successful integration of Spine Innovations into the Spineway Group.

After earning a degree as a biomedical engineer (UT Compiègne) and an Executive MBA at HEC in Paris, Sandrine Carle worked for over 20 years in the orthopedic surgery sector, and more specifically in the spinal surgery sector at Medtronic (Europe), Kyphon (USA) and Vexim (France). She held marketing and management positions in France and the USA before being appointed CEO of Spine Innovations in 2020. Ms. Carle led the creation of this entity following a spin-off in 2020 and the development of this activity between 2020 and 2022.

She led the recruitment and management of around fifteen employees, set up the functional and operational organization of the team and also obtained the company?s certification from the notified body, G-MED (France). Working alongside Stéphane Le Roux, CEO of Spineway, Sandrine Carle is responsible for conducting the Group?s overall roadmap, in particular the business development plan aimed at returning to operating breakeven, as well as all R&D projects (short, medium and long term).